The U.S. Food and Drug Administration has issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients ...

Living with Sickle Cell Disease means living with a body that is constantly working harder than most people realise. Even on ...

The Food and Drug Administration recently approved gene therapy to treat sickle cell disease among children ages 2 and older, ...

Learn how gene editing is transforming sickle cell disease treatment and why expanding access to younger children matters.

Casgevy is the first gene therapy approved for sickle cell disease and transfusion-dependent beta-thalassemia in patients aged 2 and older.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the U.S. Food and Drug Administration (FDA) has approved expanded use of CASGEVY ® (exagamglogene autotemcel) for the treatment ...

Diagnosis of sickle cell disease (SCD) is based on laboratory evaluation of hemoglobin variants, a straightforward blood test in developed countries. The primary goal is to identify the presence of ...

Sickle cell disease (SCD) is a group of painful and life-threatening genetic disorders that affect hemoglobin, the major protein that carries oxygen in red blood cells. It occurs in nearly 100,000 ...

Agios Pharmaceuticals(NASDAQ: AGIO) stock rose by 13.8% during the week through Friday morning. It's a move driven by the ...

Research has found a strong correlation between painful periods and high rates of depression, anxiety and suicidal thoughts ...

Ibemere, also a Duke Global Health Institute faculty member, set out to change that. She began organizing intensive boot ...

The Lagos University Teaching Hospital announced a successful bone marrow transplant for a person living with Sickle Cell Disease.